Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Atrial Fibrillation | Research

Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study

Authors: JungMin Choi, So‑Ryoung Lee, Eue-Keun Choi, Kyung-Yeon Lee, Hyo-Jeong Ahn, Soonil Kwon, Kyung‑Do Han, Seil Oh, Gregory Y. H. Lip

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

Diabetes mellitus (DM) duration affects incident atrial fibrillation (AF) risk; the effect of physical activity on mitigating AF risk related to varying DM duration remains unknown. We assessed the effect of physical activity on incident AF in patients with DM with respect to known DM duration.

Methods

Patients with type 2 DM who underwent the Korean National Health Insurance Service health examination in 2015–2016 were grouped by DM duration: new onset and < 5, 5–9, and ≥ 10 years. Physical activity was classified into four levels: 0, < 500, 500–999, 1,000–1,499, and ≥ 1,500 metabolic equivalent task (MET)-min/week, with the primary outcome being new-onset AF.

Results

The study enrolled 2,392,486 patients (aged 59.3 ± 12.0 years, 39.8% female) with an average follow-up of 3.9 ± 0.8 years and mean DM duration of 5.3 ± 5.1 years. Greater physical activity was associated with a lower AF risk. Lowering of incident AF risk varied with different amounts of physical activity in relation to known DM duration. Among patients with new-onset DM, DM duration < 5 years and 5–9 years and 1,000–1,499 MET-min/week exhibited the lowest AF risk. Physical activity ≥ 1,500 MET-min/week was associated with the lowest incident AF risk in patients with DM duration ≥ 10 years (by 15%), followed DM duration of 5–9 years (12%) and < 5 years (9%) (p-for-interaction = 0.002).

Conclusions

Longer DM duration was associated with a high risk of incident AF, while increased physical activity generally reduced AF risk. Engaging in > 1,500 MET-min/week was associated with the greatest AF risk reduction in patients with longer DM duration, highlighting the potential benefits of higher activity levels for AF prevention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.PubMedCrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.PubMedCrossRef
2.
go back to reference Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925–66.PubMedPubMedCentralCrossRef Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, Rosas SE, Del Prato S, Mathieu C, Mingrone G, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925–66.PubMedPubMedCentralCrossRef
3.
go back to reference Rowlands A, Davies M, Dempsey P, Edwardson C, Razieh C, Yates T. Wrist-worn accelerometers: recommending ~ 1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults. Br J Sports Med. 2021;55(14):814–5.PubMedCrossRef Rowlands A, Davies M, Dempsey P, Edwardson C, Razieh C, Yates T. Wrist-worn accelerometers: recommending ~ 1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults. Br J Sports Med. 2021;55(14):814–5.PubMedCrossRef
4.
go back to reference Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Califf RM, Holman RR, McMurray JJ, Bethel MA, et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet. 2014;383(9922):1059–66.PubMedCrossRef Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Califf RM, Holman RR, McMurray JJ, Bethel MA, et al. Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet. 2014;383(9922):1059–66.PubMedCrossRef
5.
go back to reference Geng T, Wang Y, Lu Q, Zhang YB, Chen JX, Zhou YF, Wan Z, Guo K, Yang K, Liu L, et al. Associations of New-Onset Atrial Fibrillation with risks of Cardiovascular Disease, chronic kidney Disease, and Mortality among patients with type 2 diabetes. Diabetes Care. 2022;45(10):2422–9.PubMedCrossRef Geng T, Wang Y, Lu Q, Zhang YB, Chen JX, Zhou YF, Wan Z, Guo K, Yang K, Liu L, et al. Associations of New-Onset Atrial Fibrillation with risks of Cardiovascular Disease, chronic kidney Disease, and Mortality among patients with type 2 diabetes. Diabetes Care. 2022;45(10):2422–9.PubMedCrossRef
6.
go back to reference Seyed Ahmadi S, Svensson AM, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.PubMedPubMedCentralCrossRef Seyed Ahmadi S, Svensson AM, Pivodic A, Rosengren A, Lind M. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study. Cardiovasc Diabetol. 2020;19(1):9.PubMedPubMedCentralCrossRef
7.
go back to reference Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62.PubMedPubMedCentralCrossRef Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62.PubMedPubMedCentralCrossRef
8.
go back to reference Lee SR, Choi EK, Ahn HJ, Han KD, Oh S, Lip GYH. Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study. Sci Rep. 2020;10(1):19224.PubMedPubMedCentralCrossRef Lee SR, Choi EK, Ahn HJ, Han KD, Oh S, Lip GYH. Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study. Sci Rep. 2020;10(1):19224.PubMedPubMedCentralCrossRef
9.
go back to reference Park CS, Han KD, Choi EK, Kim DH, Lee HJ, Lee SR, Oh S. Lifestyle is associated with atrial fibrillation development in patients with type 2 diabetes mellitus. Sci Rep. 2021;11(1):4676.PubMedPubMedCentralCrossRef Park CS, Han KD, Choi EK, Kim DH, Lee HJ, Lee SR, Oh S. Lifestyle is associated with atrial fibrillation development in patients with type 2 diabetes mellitus. Sci Rep. 2021;11(1):4676.PubMedPubMedCentralCrossRef
10.
go back to reference Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart. 2015;101(20):1627–30.PubMedCrossRef Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart. 2015;101(20):1627–30.PubMedCrossRef
11.
go back to reference Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11(9):1156–9.PubMedCrossRef Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11(9):1156–9.PubMedCrossRef
12.
go back to reference Park CS, Choi EK, Kyung D, Yoo J, Ahn HJ, Kwon S, Lee SR, Oh S, Lip GYH. Physical activity changes and the risk of Incident Atrial Fibrillation in patients with type 2 diabetes Mellitus: a Nationwide Longitudinal follow-up Cohort Study of 1.8 million subjects. Diabetes Care. 2023;46(2):434–40.PubMedCrossRef Park CS, Choi EK, Kyung D, Yoo J, Ahn HJ, Kwon S, Lee SR, Oh S, Lip GYH. Physical activity changes and the risk of Incident Atrial Fibrillation in patients with type 2 diabetes Mellitus: a Nationwide Longitudinal follow-up Cohort Study of 1.8 million subjects. Diabetes Care. 2023;46(2):434–40.PubMedCrossRef
13.
go back to reference Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, et al. Data Resource Profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799–800.PubMed Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, et al. Data Resource Profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799–800.PubMed
14.
go back to reference Lee W-C, Lee S-Y. National Health Screening Program of Korea. jkma 2010, 53(5):363–370. Lee W-C, Lee S-Y. National Health Screening Program of Korea. jkma 2010, 53(5):363–370.
15.
go back to reference Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–74.PubMedCrossRef Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, Marre M, Patel A, Poulter N, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–74.PubMedCrossRef
16.
go back to reference de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: a prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899.PubMedCrossRef de Jong M, Woodward M, Peters SAE. Duration of diabetes and the risk of major cardiovascular events in women and men: a prospective cohort study of UK Biobank participants. Diabetes Res Clin Pract. 2022;188:109899.PubMedCrossRef
17.
go back to reference Ohkuma T, Peters SAE, Jun M, Harrap S, Cooper M, Hamet P, Poulter N, Chalmers J, Woodward M. Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: the ADVANCE-ON study. Diabetes Obes Metab. 2020;22(10):1818–26.PubMedCrossRef Ohkuma T, Peters SAE, Jun M, Harrap S, Cooper M, Hamet P, Poulter N, Chalmers J, Woodward M. Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: the ADVANCE-ON study. Diabetes Obes Metab. 2020;22(10):1818–26.PubMedCrossRef
18.
go back to reference Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33(3):144–51.PubMedPubMedCentralCrossRef Chun MY. Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly. Korean J Fam Med. 2012;33(3):144–51.PubMedPubMedCentralCrossRef
19.
go back to reference Fogelholm M, Malmberg J, Suni J, Santtila M, Kyröläinen H, Mäntysaari M, Oja P. International Physical Activity Questionnaire: validity against fitness. Med Sci Sports Exerc. 2006;38(4):753–60.PubMedCrossRef Fogelholm M, Malmberg J, Suni J, Santtila M, Kyröläinen H, Mäntysaari M, Oja P. International Physical Activity Questionnaire: validity against fitness. Med Sci Sports Exerc. 2006;38(4):753–60.PubMedCrossRef
20.
go back to reference Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The physical activity guidelines for americans. JAMA. 2018;320(19):2020–8.PubMedPubMedCentralCrossRef Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, Olson RD. The physical activity guidelines for americans. JAMA. 2018;320(19):2020–8.PubMedPubMedCentralCrossRef
21.
go back to reference Ahn HJ, Lee SR, Choi EK, Han KD, Jung JH, Lim JH, Yun JP, Kwon S, Oh S, Lip GYH. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: a nationwide population-based cohort study. PLoS Med. 2021;18(6):e1003659.PubMedPubMedCentralCrossRef Ahn HJ, Lee SR, Choi EK, Han KD, Jung JH, Lim JH, Yun JP, Kwon S, Oh S, Lip GYH. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: a nationwide population-based cohort study. PLoS Med. 2021;18(6):e1003659.PubMedPubMedCentralCrossRef
22.
go back to reference Jeong SW, Kim SH, Kang SH, Kim HJ, Yoon CH, Youn TJ, Chae IH. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J. 2019;40(43):3547–55.PubMedPubMedCentralCrossRef Jeong SW, Kim SH, Kang SH, Kim HJ, Yoon CH, Youn TJ, Chae IH. Mortality reduction with physical activity in patients with and without cardiovascular disease. Eur Heart J. 2019;40(43):3547–55.PubMedPubMedCentralCrossRef
24.
go back to reference Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, et al. eGFR and Albuminuria in relation to risk of Incident Atrial Fibrillation: a Meta-analysis of the Jackson Heart Study, the multi-ethnic study of atherosclerosis, and the Cardiovascular Health Study. Clin J Am Soc Nephrol. 2017;12(9):1386–98.PubMedPubMedCentralCrossRef Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, et al. eGFR and Albuminuria in relation to risk of Incident Atrial Fibrillation: a Meta-analysis of the Jackson Heart Study, the multi-ethnic study of atherosclerosis, and the Cardiovascular Health Study. Clin J Am Soc Nephrol. 2017;12(9):1386–98.PubMedPubMedCentralCrossRef
25.
go back to reference Lee SR, Choi EK, Han KD, Lee SH, Oh S. Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population. Heart Rhythm. 2020;17(1):12–9.PubMedCrossRef Lee SR, Choi EK, Han KD, Lee SH, Oh S. Effect of the variability of blood pressure, glucose level, total cholesterol level, and body mass index on the risk of atrial fibrillation in a healthy population. Heart Rhythm. 2020;17(1):12–9.PubMedCrossRef
26.
go back to reference Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006;29(11):2518–27.PubMedCrossRef Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care. 2006;29(11):2518–27.PubMedCrossRef
27.
go back to reference Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692–6.PubMedPubMedCentralCrossRef Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692–6.PubMedPubMedCentralCrossRef
28.
go back to reference Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise/Physical activity in individuals with type 2 diabetes: a Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353–68.PubMedPubMedCentralCrossRef Kanaley JA, Colberg SR, Corcoran MH, Malin SK, Rodriguez NR, Crespo CJ, Kirwan JP, Zierath JR. Exercise/Physical activity in individuals with type 2 diabetes: a Consensus Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353–68.PubMedPubMedCentralCrossRef
29.
30.
go back to reference Laukkanen JA, Kunutsor SK, Ozemek C, Mäkikallio T, Lee DC, Wisloff U, Lavie CJ. Cross-country skiing and running’s association with cardiovascular events and all-cause mortality: a review of the evidence. Prog Cardiovasc Dis. 2019;62(6):505–14.PubMedCrossRef Laukkanen JA, Kunutsor SK, Ozemek C, Mäkikallio T, Lee DC, Wisloff U, Lavie CJ. Cross-country skiing and running’s association with cardiovascular events and all-cause mortality: a review of the evidence. Prog Cardiovasc Dis. 2019;62(6):505–14.PubMedCrossRef
31.
go back to reference Scheer V, Tiller NB, Doutreleau S, Khodaee M, Knechtle B, Pasternak A, Rojas-Valverde D. Potential long-term health problems Associated with Ultra-endurance running: a narrative review. Sports Med. 2022;52(4):725–40.PubMedCrossRef Scheer V, Tiller NB, Doutreleau S, Khodaee M, Knechtle B, Pasternak A, Rojas-Valverde D. Potential long-term health problems Associated with Ultra-endurance running: a narrative review. Sports Med. 2022;52(4):725–40.PubMedCrossRef
32.
go back to reference Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100(13):1037–42.PubMedCrossRef Drca N, Wolk A, Jensen-Urstad M, Larsson SC. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart. 2014;100(13):1037–42.PubMedCrossRef
33.
go back to reference Kunutsor SK, Seidu S, Mäkikallio TH, Dey RS, Laukkanen JA. Physical activity and risk of atrial fibrillation in the general population: meta-analysis of 23 cohort studies involving about 2 million participants. Eur J Epidemiol. 2021;36(3):259–74.PubMedPubMedCentralCrossRef Kunutsor SK, Seidu S, Mäkikallio TH, Dey RS, Laukkanen JA. Physical activity and risk of atrial fibrillation in the general population: meta-analysis of 23 cohort studies involving about 2 million participants. Eur J Epidemiol. 2021;36(3):259–74.PubMedPubMedCentralCrossRef
34.
go back to reference Heitmann KA, Løchen ML, Stylidis M, Hopstock LA, Schirmer H, Morseth B. Associations between physical activity, left atrial size and incident atrial fibrillation: the Tromsø Study 1994–2016. Open Heart 2022, 9(1). Heitmann KA, Løchen ML, Stylidis M, Hopstock LA, Schirmer H, Morseth B. Associations between physical activity, left atrial size and incident atrial fibrillation: the Tromsø Study 1994–2016. Open Heart 2022, 9(1).
35.
go back to reference Jung I, Moon SJ, Kwon H, Park SE, Han K-D, Rhee E-J, Lee W-Y. Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort study. Cardiovasc Prev Pharmacotherapy. 2022;4(1):42–55.CrossRef Jung I, Moon SJ, Kwon H, Park SE, Han K-D, Rhee E-J, Lee W-Y. Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort study. Cardiovasc Prev Pharmacotherapy. 2022;4(1):42–55.CrossRef
36.
go back to reference Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, et al. Risk factors, mortality, and Cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–44.PubMedCrossRef Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, et al. Risk factors, mortality, and Cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–44.PubMedCrossRef
37.
go back to reference Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page RL, Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853–8.PubMedPubMedCentralCrossRef Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page RL, Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J Gen Intern Med. 2010;25(8):853–8.PubMedPubMedCentralCrossRef
38.
go back to reference Fu L, Rao F, Lian F, Yang H, Kuang S, Wu S, Deng C, Xue Y. Mechanism of electrical remodeling of atrial myocytes and its influence on susceptibility to atrial fibrillation in diabetic rats. Life Sci. 2019;239:116903.PubMedCrossRef Fu L, Rao F, Lian F, Yang H, Kuang S, Wu S, Deng C, Xue Y. Mechanism of electrical remodeling of atrial myocytes and its influence on susceptibility to atrial fibrillation in diabetic rats. Life Sci. 2019;239:116903.PubMedCrossRef
39.
go back to reference Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM. The Association between Diabetes Mellitus and Atrial Fibrillation: clinical and mechanistic insights. Front Physiol. 2019;10:135.PubMedPubMedCentralCrossRef Bohne LJ, Johnson D, Rose RA, Wilton SB, Gillis AM. The Association between Diabetes Mellitus and Atrial Fibrillation: clinical and mechanistic insights. Front Physiol. 2019;10:135.PubMedPubMedCentralCrossRef
40.
go back to reference Zheng DL, Wu QR, Zeng P, Li SM, Cai YJ, Chen SZ, Luo XS, Kuang SJ, Rao F, Lai YY, et al. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice. Aging Cell. 2022;21(12):e13734.PubMedPubMedCentralCrossRef Zheng DL, Wu QR, Zeng P, Li SM, Cai YJ, Chen SZ, Luo XS, Kuang SJ, Rao F, Lai YY, et al. Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice. Aging Cell. 2022;21(12):e13734.PubMedPubMedCentralCrossRef
41.
go back to reference Jin MN, Yang PS, Song C, Yu HT, Kim TH, Uhm JS, Sung JH, Pak HN, Lee MH, Joung B. Physical activity and risk of Atrial Fibrillation: a Nationwide Cohort Study in General Population. Sci Rep. 2019;9(1):13270.PubMedPubMedCentralCrossRef Jin MN, Yang PS, Song C, Yu HT, Kim TH, Uhm JS, Sung JH, Pak HN, Lee MH, Joung B. Physical activity and risk of Atrial Fibrillation: a Nationwide Cohort Study in General Population. Sci Rep. 2019;9(1):13270.PubMedPubMedCentralCrossRef
42.
go back to reference Zoppini G, Cacciatori V, Raimondo D, Gemma M, Trombetta M, Dauriz M, Brangani C, Pichiri I, Negri C, Stoico V, et al. Prevalence of Cardiovascular Autonomic Neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study (VNDS). Diabetes Care. 2015;38(8):1487–93.PubMedCrossRef Zoppini G, Cacciatori V, Raimondo D, Gemma M, Trombetta M, Dauriz M, Brangani C, Pichiri I, Negri C, Stoico V, et al. Prevalence of Cardiovascular Autonomic Neuropathy in a cohort of patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study (VNDS). Diabetes Care. 2015;38(8):1487–93.PubMedCrossRef
43.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–79.PubMedCrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–79.PubMedCrossRef
44.
go back to reference Picard M, Tauveron I, Magdasy S, Benichou T, Bagheri R, Ugbolue UC, Navel V, Dutheil F. Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: a systematic review and meta-analysis. PLoS ONE. 2021;16(5):e0251863.PubMedPubMedCentralCrossRef Picard M, Tauveron I, Magdasy S, Benichou T, Bagheri R, Ugbolue UC, Navel V, Dutheil F. Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: a systematic review and meta-analysis. PLoS ONE. 2021;16(5):e0251863.PubMedPubMedCentralCrossRef
45.
go back to reference Shah MK, Moore MA, Narayan KMV, Ali MK. Trends in Lifestyle Counseling for adults with and without diabetes in the U.S., 2005–2015. Am J Prev Med. 2019;57(5):e153–61.PubMedPubMedCentralCrossRef Shah MK, Moore MA, Narayan KMV, Ali MK. Trends in Lifestyle Counseling for adults with and without diabetes in the U.S., 2005–2015. Am J Prev Med. 2019;57(5):e153–61.PubMedPubMedCentralCrossRef
46.
go back to reference Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. 2007;30(2):203–9.PubMedCrossRef Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. 2007;30(2):203–9.PubMedCrossRef
Metadata
Title
Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study
Authors
JungMin Choi
So‑Ryoung Lee
Eue-Keun Choi
Kyung-Yeon Lee
Hyo-Jeong Ahn
Soonil Kwon
Kyung‑Do Han
Seil Oh
Gregory Y. H. Lip
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-024-02194-2

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine